ACKR3 and prostate cancer: IL8 from TEC was reported to play a mediating role in prostate cancer progression (76); meanwhile, CXCR7, CXCR4, and VEGF are angiocrine factors TEC stimulate angiogenesis and enhance survival of TEC in an autocrine manner (35, 77), thus supporting tumor progression and metastasis (78).